Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes.
Saved in:
| Title: | Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes. |
|---|---|
| Authors: | Rodriguez-Calvo T; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany. teresa.rodriguez@helmholtz-munich.de., Laiho JE; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Oikarinen M; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Akhbari P; Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK., Flaxman C; Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK., Worthington T; Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK., Apaolaza P; Institute of Diabetes Research, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich-Neuherberg, Germany., Kaddis JS; Department of Diabetes and Cancer Discovery Science, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA., Kusmartseva I; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Tauriainen S; Institute of Biomedicine, University of Turku, Turku, Finland., Campbell-Thompson M; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Atkinson MA; Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., von Herrath M; Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USA.; Division of Endocrine, Diabetes and Metabolism, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.; Global Chief Medical Office, Novo Nordisk A/S, Søborg, Denmark., Hyöty H; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Department of Pediatrics, Tampere University Hospital, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland., Morgan NG; Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK., Pugliese A; Department of Diabetes Immunology, Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope, Duarte, CA, USA., Richardson SJ; Islet Biology Exeter (IBEx), Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK. s.richardson@exeter.ac.uk. |
| Corporate Authors: | nPOD-Virus group |
| Source: | Diabetologia [Diabetologia] 2025 Jun; Vol. 68 (6), pp. 1197-1210. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
